Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World watch: tracking a cancer Drug's performance in korea

NCT ID NCT06011954

Recruiting now Knowledge-focused Sponsor: Astellas Pharma Korea, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aims to collect real-world information on the safety and effectiveness of PADCEV, a treatment for advanced bladder cancer. It will follow about 200 adult patients in South Korea who are already prescribed this drug by their doctors as part of their standard care. Researchers will review medical records for up to a year to track any side effects and see how patients' cancers respond to the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site KR82001

    RECRUITING

    Goyang-si, Gyeonggi-do, 10408, South Korea

  • Site KR82002

    RECRUITING

    Seoul, 02841, South Korea

  • Site KR82003

    RECRUITING

    Seoul, 03722, South Korea

  • Site KR82004

    ACTIVE_NOT_RECRUITING

    Incheon, 21565, South Korea

  • Site KR82005

    RECRUITING

    Seoul, 03181, South Korea

  • Site KR82006

    RECRUITING

    Seoul, 07417, South Korea

  • Site KR82007

    COMPLETED

    Jeollanam-do, Jeollanam-do, 58128, South Korea

  • Site KR82008

    RECRUITING

    Suwon, Gyeonggi-do, 16500, South Korea

  • Site KR82009

    ACTIVE_NOT_RECRUITING

    Busan, 49201, South Korea

  • Site KR82010

    RECRUITING

    Busan, 48108, South Korea

  • Site KR82011

    RECRUITING

    Seoul, 07985, South Korea

  • Site KR82012

    RECRUITING

    Suwon, Gyeonggi-do, 16247, South Korea

  • Site KR82013

    RECRUITING

    Jeonju, Jeonbuk-do, 54907, South Korea

  • Site KR82014

    RECRUITING

    Daegu, 42415, South Korea

  • Site KR82015

    ACTIVE_NOT_RECRUITING

    Busan, 47392, South Korea

  • Site KR82016

    RECRUITING

    Busan, 50612, South Korea

  • Site KR82017

    RECRUITING

    Seoul, 06351, South Korea

  • Site KR82018

    RECRUITING

    Daejeon, 35365, South Korea

Conditions

Explore the condition pages connected to this study.

UROTHELIAL CANCER